Medlive has partnered with the Pancreatic Cancer Action Network (PanCAN) to expand access to critical information and resources for patients impacted by pancreatic cancer.
This collaboration, launched during Pancreatic Cancer Awareness Month, addresses a growing crisis: pancreatic cancer remains the third leading cause of cancer-related deaths in the United States, with a five-year survival rate of just 13%, according to PanCAN Data.1 Early detection and access to specialized care are crucial, yet many patients and their families still lack awareness of symptoms and treatment options.
Through the partnership, Medlive will work with PanCAN to deliver educational programming, connect patients with expert resources, and raise awareness about the disease’s warning signs.
Pancreatic cancer remains one of the most challenging diseases in oncology today.
PanCAN leads the fight through free one-to-one patient support, clinical trial connection tools like Know Your Tumor® and national advocacy efforts.
By pairing Medlive’s video-first medical education platform with PanCAN’s trusted patient-support expertise, this partnership will increase awareness, improve clinical understanding, and amplify critical resources needed across the pancreatic cancer community.
“PanCAN is proud to collaborate with Medlive to expand access to trusted, high-quality education about pancreatic cancer. As the leading organization dedicated to advancing progress against this disease, we remain deeply committed to ensuring clinicians have the resources they need and that patients are at the center of every effort. Together, we are strengthening the landscape of continuing medical education and driving meaningful impact for the pancreatic cancer community.”
— Anna Berkenblit, MD, MMSc, Chief Scientific and Medical Officer, PanCAN
The partnership will launch educational programming for patients, caregivers, and healthcare professionals. Patients and caregivers can contact PanCAN Patient Services for free personalized guidance and support. Healthcare professionals can stay tuned for upcoming CME programming.
For more information, visit https://www.medlive.com/pancan.
References
1. Sesock, Charaighn. “Pancreatic Cancer Diagnoses and Mortality Rates Climb; Five-Year Survival Rate for Pancreatic Cancer Stalls at 13%.” Pancreatic Cancer Action Network, 16 Jan. 2025, https://pancan.org/press-releases/pancreatic-cancer-diagnoses-and-mortality-rates-climb-five-year-survival-rate-for-pancreatic-cancer-stalls-at-13/.
About PanCAN
The Pancreatic Cancer Action Network (PanCAN) is the leading organization dedicated to advancing progress against pancreatic cancer. We unite the pancreatic cancer community and push every boundary to create a world where survival is the norm — not the exception. PanCAN empowers patients and caregivers with the resources and knowledge they need to advocate for the care they deserve. We are pioneering the advancement of an early detection strategy for pancreatic cancer and revolutionizing the development of advanced and personalized treatments; and we are building and mobilizing the pancreatic cancer field to ensure better outcomes for all those who face pancreatic cancer today and all those who will fight this disease tomorrow.
